Quantessence Capital LLC Ocugen, Inc. Transaction History
Quantessence Capital LLC
- $340 Billion
- Q2 2025
A detailed history of Quantessence Capital LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 200,783 shares of OCGN stock, worth $273,064. This represents 0.06% of its overall portfolio holdings.
Number of Shares
200,783Holding current value
$273,064% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
111Shares Held
63.9MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$24.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$20.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$6.88 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$5.65 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$4.74 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $295M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...